Public Health Emergency - Leading a Nation Prepared
An expanded version of GenMarks’s FDA cleared ePlex Respiratory Pathogen (RP) Panel to include assays for the simultaneous detection of SARS-CoV-2 and other respiratory pathogens.
On October 7, 2020, FDA issued an Emergency Use Authorization (EUA) to allow GenMark Diagnositcs, Inc.’s ePlex Respiratory Pathogen Panel 2 to be used to detect and/or diagnose the virus that causes COVID-19.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages